Trial · NCT02060721
Adverse events105
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 105
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Coronary Artery Disease | Cardiac disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Right Ventricular Failure | Cardiac disorders | Macitentan 10 Milligrams (mg) | 5 | 76 | 8 |
| serious | Arteriovenous Malformation | Congenital, familial and genetic disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Deafness Neurosensory | Ear and labyrinth disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Cataract | Eye disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 2 |
| serious | Vision Blurred | Eye disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Abdominal Pain | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 2 |
| serious | Gastric Polyps | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Gastrointestinal Motility Disorder | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Large Intestine Polyp | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Pancreatitis Acute | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Peritoneal Adhesions | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Vomiting | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Death | General disorders | Macitentan 10 Milligrams (mg) | 3 | 76 | 3 |
| serious | General Physical Health Deterioration | General disorders | Macitentan 10 Milligrams (mg) | 2 | 76 | 2 |
| serious | Multiple Organ Dysfunction Syndrome | General disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Peripheral Swelling | General disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 2 |
| serious | Pyrexia | General disorders | Macitentan 10 Milligrams (mg) | 2 | 76 | 2 |
| serious | Hepatitis | Hepatobiliary disorders | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
| serious | Appendiceal Abscess | Infections and infestations | Macitentan 10 Milligrams (mg) | 1 | 76 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02060721/events?page=3